Table 2.
Osteo-suppressing miRNA |
Endogenous expression during OG | miRNA target | Progenitor cell type | Animal model | Reference |
---|---|---|---|---|---|
miR-9-5p | WNT3A | Rat BMSC | NA | Zhang et al. [99] | |
miR-16-2-3p | WNT5A | Human BMSC | NA | Duan et al. [100] | |
miR-23a | NA | BMPR1B | Human PDLSC | NA | Zhang et al. [101]* |
miR-23a–27a–24-2 | HOXA5/10/11 | MC3T3-E1 | Age-related osteoporosis | Godfrey et al. [102]* | |
miR-27b-3p | SP7/OSX | Human MSMSC | Heterotopic ossification | Peng et al. [103] | |
miR-93-5p | BMP2 | Human BMSC | NA | Zhang et al. [104] | |
miR-98 | NA | BMP2 | Human BMSC | NA | Zhang et al. [105] |
miR-106b | BMP2 | Human PMSC | Glucocorticoid-induced osteoporosis | Liu et al. [106] | |
miR-125b | BMPR1B | Human BMSC | Bone defect | Wang et al. [107]* | |
miR-125b | NKIRAS2 | Human PDLSC | NA | Xue et al. [108]* | |
miR-132 | GDF5 | Human PDLSC | NA | Xu et al. [109] | |
miR-137-3p | NA | RUNX2, CXCL12 | Rat BMSC | Steroid-induced osteonecrosis of the femoral head | Kong et al. [110]* |
miR-138 | RHOC | Human DDC | NA | Zheng et al. [111]* | |
miR-139-3p | NA | ELK1 | MC3T3-E1 | NA | Wang et al. [112] |
miR-145 | FOXO1 | Human ASC | NA | Hao et al. [113] | |
miR-150 | GPNMB | Mouse BMSC | Age-related osteoporosis | Moussa et al. [114] | |
miR-155 | BMPR2, RUNX2 | C2C12, MEF | Heterotopic ossification | Liu et al. [115] | |
miR-181a-3p | BMP10 | Human BMSC | NA | Tao et al. [116] | |
miR-185 | NA | BGN | MC3T3-E1, mouse BMSC | Ovariectomy-induced osteoporosis | Cui et al. [117] |
miR-185-5p | DLX2 | MC3T3-E1 | NA | Chang et al. [118] | |
miR-193a | HMGB1 | Human BMSC | NA | Wang et al. [119] | |
miR-200a | GLS | Human BMSC | NA | Lv et al. [120] | |
miR-206 | GLS | Human BMSC | NA | Chen et al. [121] | |
miR-214-3p | NA | RUNX3 | Human MSMSC | Heterotopic ossification | Peng et al. [122] |
miR-223 | DHRS3 | Human BMSC | NA | Zhang et al. [123] | |
miR-339 | DLX5 | Human BMSC | NA | Zhou et al. [124] | |
miR-451 | YWHAZ | Cal Pre-OB | Ovariectomy-induced osteoporosis | Pan et al. [125] | |
miR-451a | NA | BMP6 | Mouse BMSC, MC3T3-E1 | Ovariectomy-induced osteoporosis | Lu et al. [126] |
miR-485-5p | SP7/OSX | Rat BMSC | NA | Zhang et al. [127] | |
miR-495 | NA | HMGA2 | Mouse Cal OB | Bone defect | Tian et al. [128] |
miR-665 | IL-6 | Human ASC | NA | Wu et al. [129] | |
miR-1187 | BMPR2, ARHGEF-9 | Mouse Cal OB | Ovariectomy-induced osteoporosis | John et al. [130] |
Legend: this list was generated from a PubMed literature search (2017–2020) to determine miRNAs that play a functional role in regulating osteoblast differentiation. This list contains miRNAs reported to suppress osteogenesis following over-expression in vitro. The second column shows endogenous expression patterns of the miRNA during in vitro osteogenesis assays: pink arrows represent reduced expression, green arrows denote increased expression and yellow arrows translate to no significant changes in expression at specific time points of osteogenic differentiation. MiRNA target genes and progenitor cell types used to study in vitro osteogenesis are also shown. Wherever applicable, the in vivo rodent model used to further test the effects of miRNA modulation on bone formation is also shown. Those studies marked with an asterisk (*) used lentiviral technology to modulate miRNA expression. All other studies utilized miRNA mimics or antagomirs. Abbreviations: ASC = adipose-derived mesenchymal stem/stromal cells; BMSC = bone marrow-derived mesenchymal stem/stromal cells; Cal OB = calvarial-derived osteoblasts; Cal Pre-OB = calvarial-derived pre-osteoblasts; DDC = dedifferentiated chondrocytes (or cartilage progenitor cells); MEF = mouse embryonic fibroblasts; MSMSC = maxillary sinus membrane stem cells; NA = not analyzed; OG = osteogenesis; PDLSC = periodontal mesenchymal stem cells; PMSC = placenta-derived mesenchymal stem cells.